It has also been shown that T-cell receptor stimulation with anti-CD3 monoclonal antibodies can specifically induce the CD8+ suppressor T-cell population, which could have a dual effect on JSLE activity and atherosclerosis progression. This evidence concerns the gene CD8A and atherosclerosis.